The US Food and Drug Administration (FDA) has cleared the Tidepool Loop, a mobile application for use with compatible continuous glucose monitors (CGMs) and insulin pumps to enable automated insulin ...
More than two years after submitting it for FDA review, Tidepool has scored the agency’s clearance for a smartphone app that allows people with Type 1 diabetes to build their own closed-loop ...
The prescription-only device works with integrated continuous glucose monitors and alternate controller enabled pumps. The Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Pregnant women with type 1 diabetes had a higher time in ...
During a session at AdvaMed’s annual MedTech Conference in Boston this fall, when asked which areas of medtech are currently looking most exciting from an R&D perspective, Medtronic CEO Geoff Martha ...